Sloan Kettering Seeks More Sanctions In Drug IP Case
The Sloan Kettering Institute again asked a New York federal judge to sanction a biopharmaceutical company and its counsel in a now-dismissed lawsuit over gene therapy patent rights, saying Wednesday the...To view the full article, register now.
Already a subscriber? Click here to view full article